Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs in Premature Ovarian Insufficiency
NCT07775391Phase 2Recruiting
- Sponsor
- Wingor Biotechnology
- Start
- Aug 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in premature ovarian insufficiency (POI), sponsored by Wingor Biotechnology. Started Aug 2026; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07775391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775391.